KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.
Krall EB, Wang B, Munoz DM, Ilic N, Raghavan S, Niederst MJ, Yu K, Ruddy DA, Aguirre AJ, Kim JW, Redig AJ, Gainor JF, Williams JA, Asara JM, Doench JG, Janne PA, Shaw AT, McDonald Iii RE, Engelman JA, Stegmeier F, Schlabach MR, Hahn WC
Elife. 2017 Feb 1;6:e18970. doi: 10.7554/eLife.18970.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 74985 | pXPR_BRD003 sgKEAP1-1 | sgKEAP1-1, puromycin selection |
| 74986 | pXPR_BRD003 sgKEAP1-2 | sgKEAP1-2, puromycin selection |